102 related articles for article (PubMed ID: 12022043)
1. [The contribution of magnetic resonance spectroscopy to the classification of high grade gliomas. The predictive value of macromolecules].
Martínez-Bisbal MC; Celda-Muñoz B; Martí-Bonmatí L; Ferrer-Ripollés P; Revert-Ventura AJ; Piquer-Belloch J; Mollá-Olmos E; Arana-Fernández de Moya E; Dosdá-Muñoz R
Rev Neurol; 2002 Feb 16-28; 34(4):309-13. PubMed ID: 12022043
[TBL] [Abstract][Full Text] [Related]
2. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
[TBL] [Abstract][Full Text] [Related]
3. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
4. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
5. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
[TBL] [Abstract][Full Text] [Related]
6. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M
Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
8. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
Ng WH; Lim T
J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
[TBL] [Abstract][Full Text] [Related]
9. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
[TBL] [Abstract][Full Text] [Related]
10. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
12. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].
Yu HW; Tanabe S; Yamaki T; Harada K; Hashi K
No Shinkei Geka; 2000 Dec; 28(12):1063-9. PubMed ID: 11193526
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
[TBL] [Abstract][Full Text] [Related]
16. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain.
Kaminogo M; Ishimaru H; Morikawa M; Ochi M; Ushijima R; Tani M; Matsuo Y; Kawakubo J; Shibata S
Neuroradiology; 2001 May; 43(5):353-63. PubMed ID: 11396738
[TBL] [Abstract][Full Text] [Related]
18. [Differences in the spectroscopy of the lesions of the remitting relapsing form of multiple sclerosis shown by magnetic resonance].
Martínez-Bisbal MC; Celda B; Martí-Bonmat L; Casanova-Estruch B; Coret-Ferrer F
Rev Neurol; 2002 May 1-15; 34(9):807-12. PubMed ID: 12134339
[TBL] [Abstract][Full Text] [Related]
19. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
20. [Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds].
Isobe T; Matsumura A; Anno I; Nagatomo Y; Yoshizawa T; Itai Y; Nose T
No Shinkei Geka; 2003 Feb; 31(2):167-72. PubMed ID: 12616652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]